Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1)

NCT01947738 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: VBY-891
DRUG: Placebo

Sponsor

Virobay Inc.

Collaborators

[object Object]